Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
baseline in murine studies 60+ Publications On triple-agonist receptor compounds +31% Energy Expenditure Resting metabolic rate increase in models 28% Visceral Fat Intra-abdominal adipose reduction observed Mechanism of Action How GLP-3 (RT) Works Triple-receptor agonism the next generation of metabolic research GLP-1 Primary Glucagon-Like Peptide-1 Incretin hormone receptor activation Suppresses appetite via hypothalamic signaling Delays gastric emptying increases satiety Stimulates glucose-dependent insulin secretion GIP Co-agonist Glucose-Dependent Insulinotropic Polypeptide Adipose tissue and beta-cell modulation Enhances GLP-1 receptor potency synergistically Modulates fat cell lipid uptake and storage Supports pancreatic beta-cell preservation Glucagon Thermogenic Glucagon Receptor Component Hepatic glucose and energy expenditure Increases hepatic glucose output regulation Promotes brown adipose thermogenesis Elevates resting energy expenditure Research Applications Primary Research Areas Obesity & Adiposity Models Studied in diet-induced obesity (DIO) rodent models demonstrating significant reductions in body weight, fat mass, and food intake compared to single-agonist controls
Per the Mounjaro and Zepbound prescribing information, take the missed dose as soon as possible if it is within 4 days (96 hours)
Science 310 , 683685 (2005)
Fujian Genohope Biotech is a leading provider of high-potency peptide APIs, offering GMP quality and worldwide delivery
